221 related articles for article (PubMed ID: 20224722)
21. Multicentric Glioma Develops via a Mutant IDH1-Independent Pathway: Immunohistochemical Study of Multicentric Glioma.
Karlowee V; Amatya VJ; Hirano H; Takayasu T; Nosaka R; Kolakshyapati M; Yoshihiro M; Takeshima Y; Sugiyama K; Arita K; Kurisu K; Yamasaki F
Pathobiology; 2017; 84(2):99-107. PubMed ID: 27553586
[TBL] [Abstract][Full Text] [Related]
22. Correlation between deregulated expression of PER2 gene and degree of glioma malignancy.
Wang F; Luo Y; Li C; Chen L
Tumori; 2014; 100(6):e266-72. PubMed ID: 25688509
[TBL] [Abstract][Full Text] [Related]
23. Alpha-internexin expression in gliomas: relationship with histological type and 1p, 19q, 10p and 10q status.
Durand K; Guillaudeau A; Pommepuy I; Mesturoux L; Chaunavel A; Gadeaud E; Porcheron M; Moreau JJ; Labrousse F
J Clin Pathol; 2011 Sep; 64(9):793-801. PubMed ID: 21653654
[TBL] [Abstract][Full Text] [Related]
24. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
25. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance.
Aldape KD; Ballman K; Furth A; Buckner JC; Giannini C; Burger PC; Scheithauer BW; Jenkins RB; James CD
J Neuropathol Exp Neurol; 2004 Jul; 63(7):700-7. PubMed ID: 15290895
[TBL] [Abstract][Full Text] [Related]
27. Chitinase 3-like protein 2 (CHI3L2, YKL-39) activates phosphorylation of extracellular signal-regulated kinases ERK1/ERK2 in human embryonic kidney (HEK293) and human glioblastoma (U87 MG) cells.
Areshkov PA; Kavsan VM
Tsitol Genet; 2010; 44(1):3-9. PubMed ID: 20201406
[TBL] [Abstract][Full Text] [Related]
28. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.
Junker N; Johansen JS; Hansen LT; Lund EL; Kristjansen PE
Cancer Sci; 2005 Mar; 96(3):183-90. PubMed ID: 15771622
[TBL] [Abstract][Full Text] [Related]
29. Glioma-associated antigen expression in oligodendroglial neoplasms. Tenascin and epidermal growth factor receptor.
McLendon RE; Wikstrand CJ; Matthews MR; Al-Baradei R; Bigner SH; Bigner DD
J Histochem Cytochem; 2000 Aug; 48(8):1103-10. PubMed ID: 10898803
[TBL] [Abstract][Full Text] [Related]
30. Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature.
Anghileri E; Castiglione M; Nunziata R; Boffano C; Nazzi V; Acerbi F; Finocchiaro G; Eoli M
Neurosurg Rev; 2016 Jan; 39(1):37-45; discussion 45-6. PubMed ID: 26212701
[TBL] [Abstract][Full Text] [Related]
31. Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas.
Neder L; Marie SK; Carlotti CG; Gabbai AA; Rosemberg S; Malheiros SM; Siqueira RP; Oba-Shinjo SM; Uno M; Aguiar PH; Miura F; Chammas R; Colli BO; Silva WA; Zago MA
Brain Pathol; 2004 Oct; 14(4):399-405. PubMed ID: 15605987
[TBL] [Abstract][Full Text] [Related]
32. Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer.
Kim SH; Das K; Noreen S; Coffman F; Hameed M
World J Surg Oncol; 2007 Feb; 5():17. PubMed ID: 17286869
[TBL] [Abstract][Full Text] [Related]
33. DJ-1 expression in glioblastomas shows positive correlation with p53 expression and negative correlation with epidermal growth factor receptor amplification.
Hinkle DA; Mullett SJ; Gabris BE; Hamilton RL
Neuropathology; 2011 Feb; 31(1):29-37. PubMed ID: 20497343
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
35. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
36. YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation.
Roslind A; Johansen JS
Methods Mol Biol; 2009; 511():159-84. PubMed ID: 19347297
[TBL] [Abstract][Full Text] [Related]
37. A complex of nuclear factor I-X3 and STAT3 regulates astrocyte and glioma migration through the secreted glycoprotein YKL-40.
Singh SK; Bhardwaj R; Wilczynska KM; Dumur CI; Kordula T
J Biol Chem; 2011 Nov; 286(46):39893-903. PubMed ID: 21953450
[TBL] [Abstract][Full Text] [Related]
38. Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas.
Iwamoto FM; Hottinger AF; Karimi S; Riedel E; Dantis J; Jahdi M; Panageas KS; Lassman AB; Abrey LE; Fleisher M; DeAngelis LM; Holland EC; Hormigo A
Neuro Oncol; 2011 Nov; 13(11):1244-51. PubMed ID: 21831900
[TBL] [Abstract][Full Text] [Related]
39. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
40. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
Marko NF; Prayson RA; Barnett GH; Weil RJ
Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
